- Home
- Publications
- Publication Search
- Publication Details
Title
Updated evidence on adjuvant treatments for gastric cancer
Authors
Keywords
-
Journal
Expert Review of Gastroenterology & Hepatology
Volume 9, Issue 12, Pages 1549-1560
Publisher
Informa UK Limited
Online
2015-09-29
DOI
10.1586/17474124.2015.1094373
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- TOPGEAR: a randomised phase III trial of perioperative ECF chemotherapy versus preoperative chemoradiation plus perioperative ECF chemotherapy for resectable gastric cancer (an international, intergroup trial of the AGITG/TROG/EORTC/NCIC CTG)
- (2015) Trevor Leong et al. BMC CANCER
- Adjuvant therapy for gastric cancer: What have we learned since INT0116?
- (2015) Alexandre A Jácome WORLD JOURNAL OF GASTROENTEROLOGY
- Comparison of International Guidelines on the Accompanying Therapy for Advanced Gastric Cancer: Reasons for the Differences
- (2015) Katrin Bauer et al. Journal of Gastric Cancer
- Phase II Study of Docetaxel and S-1 (DS) as Neoadjuvant Chemotherapy for Clinical Stage III Resectable Gastric Cancer
- (2014) Eiji Oki et al. ANNALS OF SURGICAL ONCOLOGY
- Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis
- (2014) A. Tsuburaya et al. BRITISH JOURNAL OF SURGERY
- Impact of the expression of thymidylate synthase and dihydropyrimidine dehydrogenase genes on survival in stage II/III gastric cancer
- (2014) Mitsuru Sasako et al. Gastric Cancer
- Prognostic impact of expression and methylation status of DENN/MADD domain-containing protein 2D in gastric cancer
- (2014) Mitsuro Kanda et al. Gastric Cancer
- A feasibility study of postoperative chemotherapy with S-1 and cisplatin (CDDP) for stage III/IV gastric cancer (CCOG 1106)
- (2014) Keisuke Kurimoto et al. Gastric Cancer
- Decreased expression of prenyl diphosphate synthase subunit 2 correlates with reduced survival of patients with gastric cancer
- (2014) Mitsuro Kanda et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Clinical significance of expression and epigenetic profiling ofTUSC1in gastric cancer
- (2014) Mitsuro Kanda et al. JOURNAL OF SURGICAL ONCOLOGY
- Sequential paclitaxel followed by tegafur and uracil (UFT) or S-1 versus UFT or S-1 monotherapy as adjuvant chemotherapy for T4a/b gastric cancer (SAMIT): a phase 3 factorial randomised controlled trial
- (2014) Akira Tsuburaya et al. LANCET ONCOLOGY
- Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial
- (2014) Sung Hoon Noh et al. LANCET ONCOLOGY
- Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial
- (2014) Hansjochen Wilke et al. LANCET ONCOLOGY
- Neoadjuvant Chemotherapy Followed by Surgery versus Surgery Alone for Gastric Carcinoma: Systematic Review and Meta-Analysis of Randomized Controlled Trials
- (2014) A-Man Xu et al. PLoS One
- Biomarkers for gastric cancer: prognostic, predictive or targets of therapy?
- (2014) Cecília Durães et al. VIRCHOWS ARCHIV
- Role of human epidermal growth factor receptor 2 in gastric cancer: Biological and pharmacological aspects
- (2014) Jan Trøst Jørgensen WORLD JOURNAL OF GASTROENTEROLOGY
- Adjuvant therapy for gastric cancer: Current and future directions
- (2014) Marcus Foo WORLD JOURNAL OF GASTROENTEROLOGY
- Adjuvant and/or neoadjuvant therapy for gastric cancer? A perspective review
- (2014) Rebekka Schirren et al. Therapeutic Advances in Medical Oncology
- Induction of a Pathological Complete Response by Four Courses of Neoadjuvant Chemotherapy for Gastric Cancer: Early Results of the Randomized Phase II COMPASS Trial
- (2013) Takaki Yoshikawa et al. ANNALS OF SURGICAL ONCOLOGY
- Phase II/III multicentre randomised controlled trial evaluating a strategy of primary surgery and adjuvant chemotherapy versus peri-operative chemotherapy for resectable gastric signet ring cell adenocarcinomas – PRODIGE 19 – FFCD1103 – ADCI002
- (2013) Guillaume Piessen et al. BMC CANCER
- Surgery for Gastric Cancer: Has the East versus West Issue Been Solved?
- (2013) Yasuhiro Kodera DIGESTIVE SURGERY
- Overview of Adjuvant and Neoadjuvant Therapy for Resectable Gastric Cancer in the East
- (2013) Kazumasa Fujitani DIGESTIVE SURGERY
- (Neo)-Adjuvant Chemo(-Radio) Therapy for Adenocarcinomas of the Gastroesophageal Junction and the Stomach in the West
- (2013) Hansjochen Wilke et al. DIGESTIVE SURGERY
- Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial
- (2013) Charles S Fuchs et al. LANCET
- Management of gastric cancer in Asia: resource-stratified guidelines
- (2013) Lin Shen et al. LANCET ONCOLOGY
- Gastric cancer—molecular and clinical dimensions
- (2013) Roopma Wadhwa et al. Nature Reviews Clinical Oncology
- Adjuvant Treatment for Gastric Cancer: Chemotherapy Versus Radiation
- (2013) N. Ashraf et al. ONCOLOGIST
- Neoadjuvant chemotherapy for gastric cancer in Japan: a standing position by comparing with adjuvant chemotherapy
- (2013) Takaki Yoshikawa et al. SURGERY TODAY
- Cancer statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Impact of Expression of Human Epidermal Growth Factor Receptors EGFR and ERBB2 on Survival in Stage II/III Gastric Cancer
- (2012) M. Terashima et al. CLINICAL CANCER RESEARCH
- Geographic difference in advanced gastric cancer prevalence and chemotherapy treatment results: could it really be an independent prognostic factor?
- (2012) Junichi Sakamoto et al. Gastric Cancer
- A Phase II Study of Systemic Chemotherapy with Docetaxel, Cisplatin, and S-1 (DCS) Followed by Surgery in Gastric Cancer Patients with Extensive Lymph Node Metastasis: Japan Clinical Oncology Group Study JCOG1002
- (2012) H. Katayama et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial
- (2012) Yung-Jue Bang et al. LANCET
- Neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy for patients with resectable gastric cancer (CRITICS)
- (2011) Johan L Dikken et al. BMC CANCER
- Macroscopic tumor size as an independent prognostic factor for stage II/III gastric cancer patients who underwent D2 gastrectomy followed by adjuvant chemotherapy with S-1
- (2011) Toru Aoyama et al. Gastric Cancer
- Five-Year Outcomes of a Randomized Phase III Trial Comparing Adjuvant Chemotherapy With S-1 Versus Surgery Alone in Stage II or III Gastric Cancer
- (2011) Mitsuru Sasako et al. JOURNAL OF CLINICAL ONCOLOGY
- Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial
- (2011) Marc Ychou et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Trial Comparing Capecitabine Plus Cisplatin Versus Capecitabine Plus Cisplatin With Concurrent Capecitabine Radiotherapy in Completely Resected Gastric Cancer With D2 Lymph Node Dissection: The ARTIST Trial
- (2011) Jeeyun Lee et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Feasibility Study of Adjuvant S-1 plus Docetaxel for Stage III Gastric Cancer Patients after Curative D2 Gastrectomy
- (2011) Shigeyuki Tamura et al. ONCOLOGY
- Feasibility study of adjuvant chemotherapy with S-1 plus cisplatin for gastric cancer
- (2010) D. Takahari et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- A feasibility study of postoperative chemotherapy with S-1 and cisplatin (CDDP) for gastric carcinoma (CCOG0703)
- (2010) Yasuhiro Kodera et al. Gastric Cancer
- Benefit of Adjuvant Chemotherapy for Resectable Gastric Cancer
- (2010) JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Impact of the Extent of Surgery and Postoperative Chemoradiotherapy on Recurrence Patterns in Gastric Cancer
- (2010) Johan L. Dikken et al. JOURNAL OF CLINICAL ONCOLOGY
- Neoadjuvant Chemotherapy Compared With Surgery Alone for Locally Advanced Cancer of the Stomach and Cardia: European Organisation for Research and Treatment of Cancer Randomized Trial 40954
- (2010) Christoph Schuhmacher et al. JOURNAL OF CLINICAL ONCOLOGY
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- (2010) Yung-Jue Bang et al. LANCET
- Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial
- (2010) Ilfet Songun et al. LANCET ONCOLOGY
- Phase III Comparison of Preoperative Chemotherapy Compared With Chemoradiotherapy in Patients With Locally Advanced Adenocarcinoma of the Esophagogastric Junction
- (2009) Michael Stahl et al. JOURNAL OF CLINICAL ONCOLOGY
- Gastric cancer
- (2009) Henk H Hartgrink et al. LANCET
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started